| Primary |
| Pain |
25.0% |
| Hypertension |
15.0% |
| Thrombosis |
10.0% |
| Thrombosis Prophylaxis |
10.0% |
| Convulsion |
5.0% |
| Depression |
5.0% |
| Hypertonic Bladder |
5.0% |
| Infection Prophylaxis |
5.0% |
| Nausea |
5.0% |
| Polyarthritis |
5.0% |
| Pruritus |
5.0% |
| Sleep Disorder |
5.0% |
|
| Leg Amputation |
14.3% |
| Pharmaceutical Product Complaint |
14.3% |
| Post Procedural Complication |
14.3% |
| Stevens-johnson Syndrome |
14.3% |
| Thrombocytosis |
14.3% |
| Transient Ischaemic Attack |
14.3% |
| Weight Decreased |
14.3% |
|
| Secondary |
| Hypertension |
13.4% |
| Pain |
12.5% |
| Thrombosis Prophylaxis |
9.2% |
| Supplementation Therapy |
6.6% |
| Prophylaxis |
6.1% |
| Psoas Abscess |
5.9% |
| Pneumonia |
5.7% |
| Constipation |
4.2% |
| Fluid Replacement |
4.2% |
| Electrolyte Substitution Therapy |
4.0% |
| Restlessness |
3.8% |
| Rash |
3.5% |
| Hyperglycaemia |
3.1% |
| Secretion Discharge |
3.1% |
| Sedation |
2.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.6% |
| Cardiac Failure |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Nausea |
2.4% |
| Parenteral Nutrition |
2.1% |
|
| Stevens-johnson Syndrome |
30.8% |
| Toxic Epidermal Necrolysis |
12.8% |
| Heparin-induced Thrombocytopenia |
5.1% |
| Stomatitis |
5.1% |
| Vomiting |
5.1% |
| White Blood Cell Count Increased |
5.1% |
| Arthralgia |
2.6% |
| Death |
2.6% |
| Haematocrit Decreased |
2.6% |
| Haematuria |
2.6% |
| Hepatic Enzyme Increased |
2.6% |
| Impaired Healing |
2.6% |
| Maternal Drugs Affecting Foetus |
2.6% |
| Pneumonia Aspiration |
2.6% |
| Pulmonary Embolism |
2.6% |
| Retrograde Amnesia |
2.6% |
| Sinusitis |
2.6% |
| Swollen Tongue |
2.6% |
| Thrombocythaemia |
2.6% |
| Urethritis |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
13.1% |
| Drug Use For Unknown Indication |
12.7% |
| Hypertension |
12.7% |
| Thrombosis Prophylaxis |
8.5% |
| Pain |
8.1% |
| Rheumatoid Arthritis |
8.0% |
| Prophylaxis |
7.5% |
| Analgesic Therapy |
6.6% |
| Coronary Artery Disease |
3.4% |
| Colon Cancer |
2.7% |
| Gastritis Prophylaxis |
2.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.5% |
| Constipation |
2.3% |
| Infection Prophylaxis |
1.5% |
| Psoas Abscess |
1.5% |
| Nausea |
1.4% |
| Bacterial Infection |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Diverticulitis |
1.3% |
| Insomnia |
1.3% |
|
| Neuromyelitis Optica |
10.6% |
| Gastroenteritis Clostridial |
6.4% |
| Thrombocytopenia |
6.4% |
| Clostridium Difficile Colitis |
5.3% |
| General Physical Health Deterioration |
5.3% |
| Hepatitis |
5.3% |
| Hepatitis Acute |
5.3% |
| Investigation |
5.3% |
| Stevens-johnson Syndrome |
5.3% |
| Death |
4.3% |
| Drug Interaction |
4.3% |
| Hypertension |
4.3% |
| Hypokalaemia |
4.3% |
| Impaired Healing |
4.3% |
| Pulmonary Embolism |
4.3% |
| Pyrexia |
4.3% |
| Sepsis |
4.3% |
| Toxic Epidermal Necrolysis |
4.3% |
| Alanine Aminotransferase Increased |
3.2% |
| Dizziness |
3.2% |
|
| Interacting |
| Thrombosis Prophylaxis |
15.4% |
| Pain |
11.5% |
| Coronary Artery Disease |
7.7% |
| Depression |
7.7% |
| Dyslipidaemia |
7.7% |
| Hypertension |
7.7% |
| Infection Prophylaxis |
7.7% |
| Menopausal Symptoms |
7.7% |
| Nausea |
7.7% |
| Dementia Alzheimer's Type |
3.8% |
| Folate Deficiency |
3.8% |
| Hyperuricaemia |
3.8% |
| Osteoporosis Prophylaxis |
3.8% |
| Rheumatoid Arthritis |
3.8% |
|
| Wound Infection |
75.0% |
| Upper Gastrointestinal Haemorrhage |
25.0% |
|
